1. Home
  2. TTRX vs LOVE Comparison

TTRX vs LOVE Comparison

Compare TTRX & LOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$16.25

Market Cap

298.8M

Sector

Health Care

ML Signal

HOLD

Logo The Lovesac Company

LOVE

The Lovesac Company

HOLD

Current Price

$13.63

Market Cap

249.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTRX
LOVE
Founded
2015
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
298.8M
249.4M
IPO Year
2025
2018

Fundamental Metrics

Financial Performance
Metric
TTRX
LOVE
Price
$16.25
$13.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$8.00
$25.00
AVG Volume (30 Days)
91.4K
277.5K
Earning Date
05-31-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$697,115,000.00
Revenue This Year
N/A
$4.63
Revenue Next Year
N/A
$6.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.42
52 Week Low
$2.57
$10.33
52 Week High
$14.50
$19.25

Technical Indicators

Market Signals
Indicator
TTRX
LOVE
Relative Strength Index (RSI) 75.45 33.95
Support Level $3.49 $13.39
Resistance Level N/A $13.82
Average True Range (ATR) 1.31 0.85
MACD 0.32 -0.16
Stochastic Oscillator 88.29 4.69

Price Performance

Historical Comparison
TTRX
LOVE

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

About LOVE The Lovesac Company

The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.

Share on Social Networks: